Has Shantaniece Sherrell, NP received payments from drug or device companies?

Yes. Drug and device makers reported $24,176 in general payments to Shantaniece Sherrell, NP across 856 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Shantaniece Sherrell, NP did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Shantaniece Sherrell, NP come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Shantaniece Sherrell, NP

Nurse Practitioner · Avon, INNPI 1609203884

Payments from drug & device makers

$24,176in general payments, 2019–2025

Across 856 payments — averaging $28.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Lilly USA, LLC$7K
Novartis$2K
Johnson & Johnson$1K
Merck$1K
Daiichi Sankyo Inc.$925
E.r. Squibb & Sons, L.L.C.$860
plus $11K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Lilly USA, LLC	22	$6,662
Novartis	114	$1,976
Johnson & Johnson(2 entities)	38	$1,199
Merck	44	$1,035
Daiichi Sankyo Inc.	59	$925
E.r. Squibb & Sons, L.L.C.	45	$860
AstraZeneca(2 entities)	37	$800
Sanofi	30	$798
Pfizer	39	$760
Amgen	32	$728
Bristol Myers Squibb	38	$656
Eisai Inc.	34	$650
Incyte Corporation	29	$561
Gilead(2 entities)	21	$456
Exelixis Inc.	12	$415
Takeda Pharmaceuticals U.S.A., Inc.	14	$378
Seagen Inc.	16	$336
Pharmacyclics LLC, An Abbvie Company	16	$318
AbbVie	13	$309
Astellas Pharma US Inc	14	$282
Genentech USA, Inc.	16	$262
Boehringer Ingelheim	11	$221
Acrotech Biopharma Inc.	9	$193
Beigene USA, Inc.	8	$191
Sanofi-aventis U.S. LLC	2	$176
Ipsen Biopharmaceuticals, Inc	8	$174
Bayer	6	$169
EMD Serono, Inc.	7	$151
Jazz Pharmaceuticals Inc.	6	$143
Regeneron Healthcare Solutions, Inc.	6	$138
Puma Biotechnology, Inc.	8	$133
Servier Pharmaceuticals LLC	6	$129
Pharmaessentia USA Corporation	6	$125
Global Blood Therapeutics, Inc.	3	$123
Array Biopharma Inc	7	$107
Genmab U.S., Inc.	5	$101
GSK	6	$97
Tersera Therapeutics LLC	4	$95
Coherus Oncology, Inc.	4	$93
Rigel Pharmaceuticals, Inc.	3	$89
Morphosys, US Inc.	5	$86
Blueprint Medicines Corporation	4	$79
Sobi, Inc	5	$78
Karyopharm Therapeutics Inc.	3	$72
Adaptive Biotechnologies Corporation	3	$67
Mirati Therapeutics, Inc.	2	$66
Pharmacosmos Therapeutics Inc.	3	$60
Geron Corporation	2	$52
Beone Medicines USA, Inc.	2	$50
Syndax Pharmaceuticals, Inc.	2	$49
Agios Pharmaceuticals, Inc.	2	$42
Immunocore Limited	2	$39
Octapharma USA, Inc.	1	$36
Acceleron Pharma, Inc.	2	$34
Corcept Therapeutics	1	$29
Taiho Oncology, Inc.	2	$28
Springworks Therapeutics, Inc.	1	$24
Novocure Inc.	1	$24
Stemline Therapeutics Inc.	1	$22
Sun Pharmaceutical Industries Inc.	1	$20

How this compares

$24,176 in reported general payments places this provider in the 95th percentile of 2,724 nurse practitioner providers in Indiana.

See all nurse practitioner providers in Indiana →

Medicare billing

Part B allowed, 2024

$56,837

Medicare patients

304

Services billed

765

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Avon

Kristi OrbaughIndianapolis$1.3M
Kimberly EadsPlainfield$302K
Sean GoddardFort Wayne$180K
Kacy RogersIndianapolis$77K
Kristine TaylorFort Wayne$69K
Brittany SavageIndianapolis$51K
Monica HaugerTrafalgar$47K
Rhonda HettingerClarksville$38K
Jennifer MaahsIndianapolis$36K
Amber MillerLawrenceburg$32K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →